AU2001247224A1 - 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents - Google Patents
4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agentsInfo
- Publication number
- AU2001247224A1 AU2001247224A1 AU2001247224A AU4722401A AU2001247224A1 AU 2001247224 A1 AU2001247224 A1 AU 2001247224A1 AU 2001247224 A AU2001247224 A AU 2001247224A AU 4722401 A AU4722401 A AU 4722401A AU 2001247224 A1 AU2001247224 A1 AU 2001247224A1
- Authority
- AU
- Australia
- Prior art keywords
- methyl
- oxo
- chlorobenzyl
- dihydro
- cinnolinecarboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19129100P | 2000-03-21 | 2000-03-21 | |
| US60191291 | 2000-03-21 | ||
| PCT/US2001/005811 WO2001070706A2 (en) | 2000-03-21 | 2001-03-15 | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001247224A1 true AU2001247224A1 (en) | 2001-10-03 |
Family
ID=22704885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001247224A Abandoned AU2001247224A1 (en) | 2000-03-21 | 2001-03-15 | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6624160B2 (zh) |
| EP (1) | EP1265873B1 (zh) |
| JP (1) | JP2003528087A (zh) |
| KR (1) | KR20020081479A (zh) |
| CN (1) | CN1406228A (zh) |
| AR (1) | AR027978A1 (zh) |
| AT (1) | ATE252086T1 (zh) |
| AU (1) | AU2001247224A1 (zh) |
| BR (1) | BR0109487A (zh) |
| CA (1) | CA2400000A1 (zh) |
| CZ (1) | CZ20023141A3 (zh) |
| DE (1) | DE60100999T2 (zh) |
| DK (1) | DK1265873T3 (zh) |
| EA (1) | EA200201002A1 (zh) |
| EE (1) | EE200200541A (zh) |
| ES (1) | ES2208581T3 (zh) |
| HK (1) | HK1052694A1 (zh) |
| HU (1) | HUP0300326A3 (zh) |
| IL (1) | IL151787A0 (zh) |
| MX (1) | MXPA02009251A (zh) |
| NO (1) | NO20024502L (zh) |
| NZ (1) | NZ521524A (zh) |
| PL (1) | PL357443A1 (zh) |
| PT (1) | PT1265873E (zh) |
| SI (1) | SI1265873T1 (zh) |
| SK (1) | SK12102002A3 (zh) |
| WO (1) | WO2001070706A2 (zh) |
| ZA (1) | ZA200207540B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20011349A1 (es) * | 2000-06-16 | 2002-01-19 | Upjohn Co | 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales |
| WO2014070976A1 (en) * | 2012-11-03 | 2014-05-08 | Boehringer Ingelheim International Gmbh | Inhibitors of cytomegalovirus |
| KR20230170813A (ko) | 2018-09-12 | 2023-12-19 | 노파르티스 아게 | 항바이러스 피리도피라진디온 화합물 |
| US11667613B2 (en) | 2019-09-26 | 2023-06-06 | Novartis Ag | Antiviral pyrazolopyridinone compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8513639D0 (en) | 1985-05-30 | 1985-07-03 | Ici America Inc | Cinnoline compounds |
| GB8702288D0 (en) * | 1987-02-02 | 1987-03-11 | Erba Farmitalia | Cinnoline-carboxamides |
| ATE239477T1 (de) | 1995-08-02 | 2003-05-15 | Darwin Discovery Ltd | Chinolone und deren therapeutische verwendung |
| CA2225555A1 (en) | 1995-08-02 | 1997-02-13 | Chiroscience Limited | Quinolones and their therapeutic use |
| NZ505362A (en) | 1997-12-22 | 2004-12-24 | Upjohn Co | 4-hydroxyquinoline-3-carboxamides and -hydrazides useful as antiviral agents |
| WO1999038867A1 (fr) | 1998-01-29 | 1999-08-05 | Suntory Limited | Derives de 1-cycloalkyle-1,8-naphthyridine-4-one presentant une activite inhibitrice de la phosphodiesterase iv |
-
2001
- 2001-03-15 EP EP01920138A patent/EP1265873B1/en not_active Expired - Lifetime
- 2001-03-15 ES ES01920138T patent/ES2208581T3/es not_active Expired - Lifetime
- 2001-03-15 CN CN01805756A patent/CN1406228A/zh active Pending
- 2001-03-15 BR BR0109487-4A patent/BR0109487A/pt not_active IP Right Cessation
- 2001-03-15 DK DK01920138T patent/DK1265873T3/da active
- 2001-03-15 HU HU0300326A patent/HUP0300326A3/hu unknown
- 2001-03-15 CZ CZ20023141A patent/CZ20023141A3/cs unknown
- 2001-03-15 PL PL01357443A patent/PL357443A1/xx not_active Application Discontinuation
- 2001-03-15 SK SK1210-2002A patent/SK12102002A3/sk unknown
- 2001-03-15 SI SI200130046T patent/SI1265873T1/xx unknown
- 2001-03-15 WO PCT/US2001/005811 patent/WO2001070706A2/en active IP Right Grant
- 2001-03-15 JP JP2001568916A patent/JP2003528087A/ja active Pending
- 2001-03-15 PT PT01920138T patent/PT1265873E/pt unknown
- 2001-03-15 CA CA002400000A patent/CA2400000A1/en not_active Abandoned
- 2001-03-15 AU AU2001247224A patent/AU2001247224A1/en not_active Abandoned
- 2001-03-15 EA EA200201002A patent/EA200201002A1/ru unknown
- 2001-03-15 EE EEP200200541A patent/EE200200541A/xx unknown
- 2001-03-15 US US09/808,836 patent/US6624160B2/en not_active Expired - Fee Related
- 2001-03-15 IL IL15178701A patent/IL151787A0/xx unknown
- 2001-03-15 MX MXPA02009251A patent/MXPA02009251A/es active IP Right Grant
- 2001-03-15 NZ NZ521524A patent/NZ521524A/en unknown
- 2001-03-15 DE DE60100999T patent/DE60100999T2/de not_active Expired - Fee Related
- 2001-03-15 AT AT01920138T patent/ATE252086T1/de not_active IP Right Cessation
- 2001-03-15 KR KR1020027012466A patent/KR20020081479A/ko not_active Application Discontinuation
- 2001-03-20 AR ARP010101303A patent/AR027978A1/es unknown
-
2002
- 2002-09-19 ZA ZA200207540A patent/ZA200207540B/en unknown
- 2002-09-20 NO NO20024502A patent/NO20024502L/no not_active Application Discontinuation
-
2003
- 2003-07-09 HK HK03104900.8A patent/HK1052694A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1265873E (pt) | 2004-03-31 |
| CN1406228A (zh) | 2003-03-26 |
| WO2001070706A2 (en) | 2001-09-27 |
| US20020045619A1 (en) | 2002-04-18 |
| ES2208581T3 (es) | 2004-06-16 |
| EE200200541A (et) | 2004-04-15 |
| CZ20023141A3 (cs) | 2003-02-12 |
| NZ521524A (en) | 2004-04-30 |
| HUP0300326A3 (en) | 2003-09-29 |
| PL357443A1 (en) | 2004-07-26 |
| SI1265873T1 (en) | 2004-02-29 |
| DK1265873T3 (da) | 2004-02-16 |
| ZA200207540B (en) | 2003-12-19 |
| HUP0300326A2 (hu) | 2003-07-28 |
| JP2003528087A (ja) | 2003-09-24 |
| US6624160B2 (en) | 2003-09-23 |
| EP1265873B1 (en) | 2003-10-15 |
| HK1052694A1 (zh) | 2003-09-26 |
| DE60100999D1 (en) | 2003-11-20 |
| NO20024502L (no) | 2002-11-20 |
| WO2001070706A3 (en) | 2002-05-10 |
| IL151787A0 (en) | 2003-04-10 |
| CA2400000A1 (en) | 2001-09-27 |
| SK12102002A3 (sk) | 2003-03-04 |
| KR20020081479A (ko) | 2002-10-26 |
| ATE252086T1 (de) | 2003-11-15 |
| DE60100999T2 (de) | 2004-09-02 |
| AR027978A1 (es) | 2003-04-23 |
| EA200201002A1 (ru) | 2003-02-27 |
| MXPA02009251A (es) | 2004-04-05 |
| NO20024502D0 (no) | 2002-09-20 |
| BR0109487A (pt) | 2003-06-10 |
| EP1265873A2 (en) | 2002-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK112893A3 (en) | Benzofuran derivatives, method of their preparation and pharmaceutical compositions containing them | |
| US6727248B2 (en) | Substituted quinolinecarboxamides as antiviral agents | |
| US6653307B2 (en) | 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | |
| AU2001268075A1 (en) | 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | |
| EP1265873B1 (en) | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents | |
| US6413958B2 (en) | 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents | |
| US6458788B1 (en) | 4-hydroxycinnoline-3-carboxyamides as antiviral agents | |
| US20020019413A1 (en) | 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents | |
| ZA200209531B (en) | 1-Aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents. |